+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Hederacoside C

BP0708
14216-03-6
98%
Phytopurify
Hedera helix
Hederacoside C is one of the active ingredients in Hedera helix leaf extract (Ivy Ex.) and AG NPP709, a new botanical drug to treat acute respiratory infection and chronic inflammatory bronchitis. Hederacoside C has antispasmodic activity. Hederacoside C is a potent competitive inhibitor for serine protease porcine pancreatic elastase, shows comparable IC 50 value is 40.6 uM; it also non-competitively inhibits hyaluronidase activity in a dose- dependent fashion, shows comparable IC 50 value is 280.4 uM. Kalopanaxsaponin B is a triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus. It has a role as an anti-inflammatory agent and a plant metabolite. It is a pentacyclic triterpenoid, a carboxylic ester and a triterpenoid saponin. It is functionally related to a hederagenin.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0708-20mg 20mg
BP0708-100mg 100mg
BP0708-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

MAPK1 TNF MAPK8 NFKB1 IL6 IL1B IL17A IL23R
MAPK1 TNF MAPK8 NFKB1 IL6 IL1B IL17A
TNF NFKB1 IL1B DEFB1

Product drug property prediction parameters

  • 412.8200

  • 1.8840

  • 1.8839

  • .3485

  • .5437

  • .1302

  • Low

  • 70.6480

  • 7.2562

  • Yes

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • Yes